Regulating the game announces finalists for inaugural RTG global awards

Regulating the Game has revealed the finalists for the first edition of the RTG Global Awards. The announcement highlights achievements in gaming regulation worldwide. It was published on February 1, 2026.

The announcement of the finalists for the inaugural RTG Global Awards was made by Regulating the Game on February 1, 2026, at 08:28:24+08:00. This event introduces a new recognition platform focused on the gaming industry, particularly in areas like land-based and online operations across Asia and beyond.

While specific finalist details were not detailed in the initial publication, the awards come amid broader developments in the sector. For context, recent reports note Macau's economic recovery, with GDP rising 4.7% to US$51.9 billion in 2025, reaching 89.6% of 2019 levels. Hotel occupancy in Macau also improved to 89.4%, up 3.1 percentage points year-on-year, with 14,560,000 guests.

Other regional updates include Melco Resorts & Entertainment's 'House of Dancing Water' receiving the Macao SAR Government’s Medal of Merit – Tourism in 2025. Additionally, KT Lim, Chairman and CEO of Genting Bhd, took on the role of Chairman and Director at Resorts World Sentosa in Singapore.

These developments underscore the evolving landscape of gaming regulation and operations that the RTG Global Awards aim to celebrate.

Related Articles

Press conference scene announcing new Grammy categories and rule changes.
Image generated by AI

Grammys announce five new categories and rule changes

Reported by AI Image generated by AI

The Recording Academy announced five new Grammy categories and several rule updates on June 16. The changes will apply to the 69th annual awards, scheduled for February 7, 2027.

The Senate Economy Commission discussed a bill to regulate online betting platforms on Tuesday, following an SII resolution on tax collection.

Reported by AI

Hong Kong is recruiting for its Centre for Medical Products Regulation, expected to launch by the fourth quarter of 2026, as it seeks World Health Organization recognition and aims for independent drug approvals by 2030.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline